Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach. 2021

Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
Laboratório de Modelagem Molecular, Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará-UFPA, Guamá, Belém-PA 66075-10, Brazil.

Tyrosinases belong to the functional copper-containing proteins family, and their structure contains two copper atoms, in the active site, which are coordinated by three histidine residues. The biosynthesis of melanin in melanocytes has two stages depending on the actions of the natural substrates L-DOPA and L-tyrosine. The dysregulation of tyrosinase is involved in skin cancer initiation. In the present study, using molecular modeling tools, we analyzed the inhibition activity of tyrosinase activity using kojic acid (KA) derivatives designed from aromatic aldehydes and malononitrile. All derivatives showed conformational affinity to the enzyme active site, and a favorable distance to chelate the copper ion, which is essential for enzyme function. Molecular dynamics simulations revealed that the derivatives formed promising complexes, presenting stable conformations with deviations between 0.2 and 0.35 Å. In addition, the investigated KA derivatives showed favorable binding free energies. The most stable KA derivatives showed the following binding free energies: -17.65 kcal mol-1 (D6), -18.07 kcal mol-1 (D2), -18.13 (D5) kcal mol-1, and -10.31 kcal mol-1 (D4). Our results suggest that these derivatives could be potent competitive inhibitors of the natural substrates of L-DOPA (-12.84 kcal mol-1) and L-tyrosine (-9.04 kcal mol-1) in melanogenesis.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008543 Melanins Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. Allomelanins,Melanin,Phaeomelanins
D008544 Melanocytes Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES. Melanocyte
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D011753 Pyrones Keto-pyrans.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014442 Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Dopa Oxidase,Phenoloxidase,Tyrosinase,Cresolase,Phenol Oxidase,Phenoloxidase A,Phenoloxidase B,Monooxygenase, Monophenol,Oxidase, Dopa,Oxidase, Phenol

Related Publications

Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
October 2009, Bioorganic & medicinal chemistry letters,
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
November 2021, Food chemistry,
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
September 2020, European journal of medicinal chemistry,
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
July 2019, Bioorganic chemistry,
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
November 2015, Chemical biology & drug design,
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
July 2014, Molecules (Basel, Switzerland),
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
March 2024, Food chemistry: X,
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
November 2022, Molecules (Basel, Switzerland),
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
October 2020, Journal of molecular modeling,
Richelly Cardoso, and Renan Valente, and Clauber Henrique Souza da Costa, and João Lidio da S Gonçalves Vianez, and Kauê Santana da Costa, and Fábio Alberto de Molfetta, and Cláudio Nahum Alves
June 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!